Log in with your email address username.


[Comment] PARTNERs in the future of surgical aortic valve replacement

Aortic stenosis is the most common valve disease, the occurrence of which increases with age.1 Incidence of aortic stenosis is expected to rise because of population ageing. For decades, surgical aortic valve replacement (SAVR) was the gold standard of care for individuals with symptomatic severe aortic stenosis—in properly selected patients, substantially improving symptoms and life expectancy.1 Although physicians have learned how to care for critically ill old patients and enable many to survive major surgical procedures, operating on patients at very high risk is often not suitable.